Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × tislelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 9 Advanced Solid Tumor 6 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumour 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor 1 Simpson-Golabi-Behmel syndrome 1 Pseudomyxoma Peritonei 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasm, Residual 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Metastatic Solid Tumors 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 2 tazemetostat 1 romidepsin 1 pembrolizumab 1 glofitamab 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 brincidofovir 1 belinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Polymerase Chain Reaction 1 Melphalan 1 Lactones 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Doxorubicin 1 Depsipeptides 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 Bendamustine Hydrochloride 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡